DK633374A - - Google Patents
Info
- Publication number
- DK633374A DK633374A DK633374A DK633374A DK633374A DK 633374 A DK633374 A DK 633374A DK 633374 A DK633374 A DK 633374A DK 633374 A DK633374 A DK 633374A DK 633374 A DK633374 A DK 633374A
- Authority
- DK
- Denmark
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
- C07K1/061—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
- C07K1/062—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups for alpha- or omega-carboxy functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
- C07K1/042—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers characterised by the nature of the carrier
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2360794A DE2360794C2 (de) | 1973-12-06 | 1973-12-06 | Verfahren zur Herstellung von Peptiden |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK633374A true DK633374A (fr) | 1975-07-21 |
Family
ID=5900062
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK633374A DK633374A (fr) | 1973-12-06 | 1974-12-05 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US3960830A (fr) |
| JP (1) | JPS5088003A (fr) |
| BE (1) | BE823064A (fr) |
| CH (1) | CH605679A5 (fr) |
| DE (1) | DE2360794C2 (fr) |
| DK (1) | DK633374A (fr) |
| FR (1) | FR2253736B1 (fr) |
| GB (1) | GB1464938A (fr) |
| IE (1) | IE40281B1 (fr) |
| LU (1) | LU71415A1 (fr) |
| NL (1) | NL7415602A (fr) |
| SE (1) | SE7415305L (fr) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH611878A5 (fr) * | 1974-07-04 | 1979-06-29 | Takeda Chemical Industries Ltd | |
| DE2930542A1 (de) * | 1979-07-27 | 1981-02-12 | Hoechst Ag | Neue insulinderivate und verfahren zu ihrer herstellung |
| US4585757A (en) * | 1984-07-27 | 1986-04-29 | Texas Tech University Health Sciences Center | Hypotensive active peptides |
| US4766106A (en) * | 1985-06-26 | 1988-08-23 | Cetus Corporation | Solubilization of proteins for pharmaceutical compositions using polymer conjugation |
| US5206344A (en) * | 1985-06-26 | 1993-04-27 | Cetus Oncology Corporation | Interleukin-2 muteins and polymer conjugation thereof |
| US4847325A (en) * | 1988-01-20 | 1989-07-11 | Cetus Corporation | Conjugation of polymer to colony stimulating factor-1 |
| US4908404A (en) * | 1988-08-22 | 1990-03-13 | Biopolymers, Inc. | Synthetic amino acid-and/or peptide-containing graft copolymers |
| US5162430A (en) * | 1988-11-21 | 1992-11-10 | Collagen Corporation | Collagen-polymer conjugates |
| US5510418A (en) * | 1988-11-21 | 1996-04-23 | Collagen Corporation | Glycosaminoglycan-synthetic polymer conjugates |
| US5306500A (en) * | 1988-11-21 | 1994-04-26 | Collagen Corporation | Method of augmenting tissue with collagen-polymer conjugates |
| US5565519A (en) * | 1988-11-21 | 1996-10-15 | Collagen Corporation | Clear, chemically modified collagen-synthetic polymer conjugates for ophthalmic applications |
| US5166322A (en) * | 1989-04-21 | 1992-11-24 | Genetics Institute | Cysteine added variants of interleukin-3 and chemical modifications thereof |
| JPH0520266U (ja) * | 1991-01-31 | 1993-03-12 | 松下電器産業株式会社 | 電気部品の接続装置 |
| DK0536671T3 (da) * | 1991-10-07 | 1996-08-12 | Hoechst Ag | Carboxylsyreester-beskyttelsesgrupper, en fremgangsmåde til deres fremstilling, kobling til funktionelle grupper samt deres anvendelser |
| PT876165E (pt) * | 1995-12-18 | 2006-10-31 | Angiotech Biomaterials Corp | Composicoes de polimeros reticulados e processos para a sua utilizacao |
| US7883693B2 (en) | 1995-12-18 | 2011-02-08 | Angiodevice International Gmbh | Compositions and systems for forming crosslinked biomaterials and methods of preparation of use |
| US6833408B2 (en) * | 1995-12-18 | 2004-12-21 | Cohesion Technologies, Inc. | Methods for tissue repair using adhesive materials |
| US6458889B1 (en) | 1995-12-18 | 2002-10-01 | Cohesion Technologies, Inc. | Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use |
| US20030220258A1 (en) * | 2001-12-21 | 2003-11-27 | Robbert Benner | Treatment of ischemic events |
| HK1043801A1 (zh) * | 1998-08-28 | 2002-09-27 | 格莱风科学公司 | 精确长度的聚酰胺链、其制备方法和其与蛋白质的缀合物 |
| DK1656952T3 (da) * | 1998-10-16 | 2014-01-20 | Biogen Idec Inc | Polyalkylenglycolkonjugater af interferon beta-1A og anvendelser deraf |
| US7358330B2 (en) * | 2001-03-29 | 2008-04-15 | Biotempt B.V. | Immunoregulatory compositions |
| EP1300418A1 (fr) * | 2001-10-04 | 2003-04-09 | Erasmus Universiteit Rotterdam | Régulation génétique par des oligopeptides |
| US20080242837A1 (en) * | 2001-12-21 | 2008-10-02 | Khan Nisar A | Peptide compositions |
| US8129330B2 (en) * | 2002-09-30 | 2012-03-06 | Mountain View Pharmaceuticals, Inc. | Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof |
| US20040225077A1 (en) * | 2002-12-30 | 2004-11-11 | Angiotech International Ag | Drug delivery from rapid gelling polymer composition |
| JP2006519766A (ja) * | 2002-12-30 | 2006-08-31 | アンジオテック インターナショナル アクツィエン ゲゼルシャフト | 組織反応性化合物および組成物、ならびにそれらの使用法 |
| US7517529B2 (en) * | 2003-04-08 | 2009-04-14 | Biotempt B.V. | Treatment of type I diabetes |
| US20090227505A1 (en) * | 2004-01-07 | 2009-09-10 | Biotempt B.V. | Methods and uses for protein breakdown products |
| WO2006083260A2 (fr) | 2004-04-28 | 2006-08-10 | Angiotech Biomaterials Corporation | Compositions et systemes pour la formation de biomateriaux reticules et procedes associes de preparation et d'utilisation |
| EP1789437A4 (fr) * | 2004-07-30 | 2008-11-05 | Sinai School Medicine | Inhibiteurs de npc1l1 et npc1l1 et procédés d'utilisation associés |
| US8303973B2 (en) | 2004-09-17 | 2012-11-06 | Angiotech Pharmaceuticals (Us), Inc. | Multifunctional compounds for forming crosslinked biomaterials and methods of preparation and use |
| EP1927584B1 (fr) * | 2005-09-20 | 2016-11-30 | Jitsubo Co., Ltd. | Support de séparation, procédé de séparation d un composé et procédé de synthèse de peptide utilisant le support |
| EP1864692A1 (fr) * | 2006-06-07 | 2007-12-12 | Biotempt B.V. | Utilisation de peptides pour la protection contre les radiolésions |
| PT2120991E (pt) * | 2007-02-12 | 2014-05-02 | Biotempt Bv | Tratamento d a hemorragia traumática com oligopéptidos curtos |
| EP2062909A1 (fr) * | 2007-11-21 | 2009-05-27 | SOLVAY (Société Anonyme) | Production de peptides et procédé de purification |
| US9051349B2 (en) | 2007-11-21 | 2015-06-09 | Alba Therapeutics Corporation | Larazotide acetate compositions |
| HUE026131T2 (en) | 2008-12-29 | 2016-05-30 | Trevena Inc | Beta-arresin effector and preparations and methods for their use |
| CA2938986A1 (fr) * | 2014-02-07 | 2015-08-13 | Trevena, Inc. | Formes cristallines et amorphes d'un effecteur beta-arrestine |
| US9611293B2 (en) | 2014-05-19 | 2017-04-04 | Trevena, Inc. | Synthesis of beta-arrestin effectors |
| WO2016011037A1 (fr) * | 2014-07-14 | 2016-01-21 | Peg Biosciences, Inc. | Promédicaments d'enképhaline polymères |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE337223B (fr) * | 1967-05-23 | 1971-08-02 | Pharmacia Ab | |
| US3502545A (en) * | 1968-09-27 | 1970-03-24 | Monsanto Co | Process for the separation of water-soluble polymeric materials from unbound protein or peptide using semiporous gel |
-
1973
- 1973-12-06 DE DE2360794A patent/DE2360794C2/de not_active Expired
-
1974
- 1974-11-29 NL NL7415602A patent/NL7415602A/xx unknown
- 1974-12-04 LU LU71415A patent/LU71415A1/xx unknown
- 1974-12-04 US US05/529,519 patent/US3960830A/en not_active Expired - Lifetime
- 1974-12-05 CH CH1619674A patent/CH605679A5/xx not_active IP Right Cessation
- 1974-12-05 DK DK633374A patent/DK633374A/da unknown
- 1974-12-05 IE IE2512/74A patent/IE40281B1/en unknown
- 1974-12-06 BE BE151258A patent/BE823064A/fr unknown
- 1974-12-06 SE SE7415305A patent/SE7415305L/xx not_active Application Discontinuation
- 1974-12-06 JP JP49141098A patent/JPS5088003A/ja active Pending
- 1974-12-06 GB GB5298774A patent/GB1464938A/en not_active Expired
- 1974-12-06 FR FR7440004A patent/FR2253736B1/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| SE7415305L (fr) | 1975-06-09 |
| LU71415A1 (fr) | 1976-11-11 |
| NL7415602A (nl) | 1975-06-10 |
| GB1464938A (en) | 1977-02-16 |
| DE2360794C2 (de) | 1984-12-06 |
| FR2253736A1 (fr) | 1975-07-04 |
| IE40281L (en) | 1975-06-06 |
| IE40281B1 (en) | 1979-04-25 |
| BE823064A (fr) | 1975-06-06 |
| FR2253736B1 (fr) | 1978-09-15 |
| DE2360794A1 (de) | 1975-06-26 |
| US3960830A (en) | 1976-06-01 |
| CH605679A5 (fr) | 1978-10-13 |
| JPS5088003A (fr) | 1975-07-15 |